Search Results

She earned her M.Sc. in Zoology and Neurobiology before completing a Ph.D. in Biology and Pharmacology

Instead, he ended up getting interested in membrane protein as he followed the biology of a bacterial

She developed expertise over the past two decades studying structure/function relationships of GPCRs

premier scientific meeting bringing together leaders and innovators in G Protein-Coupled Receptor (GPCR) biology workshops, and networking sessions covering the latest advancements and challenges in Membrane Receptor biology

Hicks About Chloe Hicks Chloe Hicks will graduate from Duke University this spring with a B.S degree in Biology

David Sykes " David Andrew Sykes, BSc Hons Pharmacology, MSc Molecular Biology and Biochemistry, PhD

Paul Insel was at the FASEB experimental biology meeting in Atlantic City.

Gabriele Kockelkoren About Gabriele Kockelkoren I have a strong background in both physics and molecular biology

Tom initially focused on structure-activity relationships underlying spectral tuning and identified a micro-domains” and the “helix movement model of receptor activation” were confirmed later when crystal structures

of Medicine and Professor of Biochemistry, Chemistry, and Pathology at the Duke University Medical Center

Louis University in 1983, he subsequently trained in pharmacology (NIH), molecular biology, and psychiatry

Gasser " I received my BS and MS in Zoology & Physiology at the University of Wyoming, where I studied I received my PhD in Biology at Arizona State University, where I worked in the lab of Miles Orchinik

During the past 2 decades, my research mainly focused on chemokine receptor structure/function relationships

category on top left corner (up to 2 categories max) Abstract categories Signaling Trafficking Metabolism Structure Up Logo Contest Enter our logo contest for a chance to have your design represent the upcoming event.

Nicola J Smith is an expert in molecular pharmacology with a track record in exploring GPCR structure-function

Nigel Bunnett at the NYU Pain Research Center as a postdoctoral researcher. Badr recounting his journey from struggling with math in an engineering physics degree to excelling in biology

research laboratory of around 15 staff supported by basic research grants investigating aspects of disease biology Andrew is also the Director of the Advanced Research Centre (ARC) a collaborative initiative at the University

The Tiberi Lab pursues the study of the molecular, structural, pharmacological and signaling features

His doctoral research focused on the structural and functional characterization of bitter taste receptors

fascinating career journeys, groundbreaking discoveries, and impactful contributions of experts in GPCR biology trajectory, discoveries, and how their research contributed to the shared pool of knowledge about GPCR biology

re introducing foundational concepts or diving into advanced methodologies, our platform provides a structured Outline the structure : determine the number of modules and estimated duration (check the 'Course formats While this is not a real-time booking tool, it serves as a guideline to help structure our course lineup

He guided the in vitro biology efforts of the company for numerous drug discovery campaigns.

field of pharmacology and biochemistry of GPCR and the crucial role of the lipidic environment on their structure

He did B.Sc. in biology at McGill University and received his Ph.D. under the mentorship of Dr.

Langmead is Professor, Deputy Director, and Better Medicines Theme Leader of the Neuromedicines Discovery Centre the co-founder and CEO of Phrenix Therapeutics, a biotech spin-out from the Neuromedicines Discovery Centre UK-based biotechnology company (2009-2012), where he was responsible all of the company’s discovery biology

I completed my Ph.D. in molecular and cell biology at UConn and then joined Addgene as a Quality Control

investigators from academia and industry to discuss and debate existing and novel concepts in GPCR biology

— blending pharmacological fundamentals with bold experimentation and a deep commitment to patient-centered